Purpose: The purpose of this study is to evaluate the decision-making experience of families choosing treatment with ustekinumab for their children with IBD.
Study Period: March 2021-February 2022
Contact: Ellen Lipstein
Purpose: The purpose of this study is to evaluate the decision-making experience of families choosing treatment with ustekinumab for their children with IBD.
Study Period: March 2021-February 2022
Contact: Ellen Lipstein
Built by Veracity Media on NationBuilder